Q8WQX9 (Q8WQX9_9TRYP) Trypanosoma brucei
Phosphodiesterase UniProtKBInterProInteractive Modelling
930 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
24 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of TbrPDEB1 | homo-2-mer | 2×ZN; 2×MG; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-038 | monomer | 1×ZN; 1×MG; 6×GAI; 10×EDO; 1×FMT; 1×8Z4; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-1439 | monomer | 5×GAI; 1×D68; 1×ZN; 1×MG; 4×FMT; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-001 | monomer | 1×ZN; 1×MG; 2×FMT; 4×GOL; 1×PEG; 3×GAI; 1×6M5; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-1361 | monomer | 1×ZN; 1×MG; 3×FMT; 2×GAI; 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-008 | monomer | 1×ZN; 1×MG; 1×LQY; 3×FMT; 2×GAI; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-617 | monomer | 1×QWT; 1×ZN; 1×MG; 2×PEG; 5×GOL; 3×GAI; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-053 | monomer | 1×MG; 1×ZN; 7×GAI; 3×EDO; 1×FMT; 1×JX2; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-0769 | monomer | 1×ZN; 1×MG; 3×FMT; 2×GAI; 3×GOL; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-1335 | monomer | 1×MG; 1×ZN; 3×GAI; 1×FFZ; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-356 | monomer | 1×D62; 1×ZN; 1×MG; 1×GAI; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-656 | monomer | 1×ZN; 1×MG; 2×FMT; 4×GAI; 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-039 | monomer | 1×ZN; 1×MG; 3×FMT; 1×GAI; 1×908; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-055 | monomer | 1×ZN; 1×MG; 1×FMT; 1×GOL; 3×GAI; 1×K3N; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-048 | monomer | 1×MG; 1×ZN; 12×EDO; 8×GAI; 4×FMT; 1×E6Z; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-937 | monomer | 1×ZN; 1×MG; 1×FMT; 1×GAI; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-226 | monomer | 4×GAI; 1×D5T; 1×ZN; 1×MG; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-340 | monomer | 1×ZN; 1×MG; 1×GOL; 1×FMT; 1×CVL; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-1018 | monomer | 1×ZN; 1×MG; 2×FMT; 3×GAI; 1×GOL; 1×K3W; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-1086 | monomer | 1×ZN; 1×MG; 1×D5Z; 3×FMT; 2×GAI; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-007 | monomer | 1×MG; 1×ZN; 3×GOL; 1×E8H; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-1039 | monomer | 1×ZN; 1×MG; 1×FMT; 2×GAI; 1×GOL; 1×K1Q; | ||||
| Assess | ||||||
| Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-637 | monomer | 1×ZN; 1×MG; 4×GAI; 2×FMT; | ||||
| Assess | ||||||
| TbrPDEB1-inhibitor complex | monomer | 1×ZN; 1×MG; 1×PIL; 1×GAI; 1×GOL; | ||||
| Assess | ||||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6mzb.1.A | monomer | 0.60 | 1×ZN; | 26.49 | ||
| Assess | ||||||
| 1ykd.1.A | monomer | 0.60 | 33.04 | |||
| Assess | ||||||
| 3ibj.1.A | monomer | 0.59 | 1×ZN; 1×MG; | 28.57 | ||
| Assess | ||||||